HIV

The HIV pipeline: 66 tracked drugs, 25 approved for this indication.

25 approved / phase 410 Phase 33 Phase 2/313 Phase 22 Phase 1/211 Phase 12 preclinical / unstaged

Compare the share prices of listed companies in HIV →

Total attributable cost

$49.2B

$44,569/patient

Drug spend

Not yet sourced

How this is calculated ↗

All stages, diagnosed (2024 estimate) · US

The HIV pipeline

Key trial results for every approved and late-stage drug: HIV results by drug.

← all assets